Evidence map›Paper›PMID 36225331›Full record

ArticleERJ open research2022

Vasoreactive phenotype in children with pulmonary arterial hypertension and syncope.

Alexandra N Linder, Jill Hsia, Sheila V Krishnan, Erika B Rosenzweig, Usha S Krishnan

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Alexandra N LinderDivision of Pediatric Cardiology, Dept of Pediatrics, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA.ORCID https://orcid.org/0000-0002-5426-5157
Jill HsiaDivision of Pediatric Cardiology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Sheila V KrishnanDivision of Pediatric Cardiology, Dept of Pediatrics, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA.
Erika B RosenzweigDivision of Pediatric Cardiology, Dept of Pediatrics, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA.ORCID https://orcid.org/0000-0003-4849-214X
Usha S KrishnanDivision of Pediatric Cardiology, Dept of Pediatrics, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, NY, USA.
NewYork–Presbyterian Hospital · USChildren's Hospital of Philadelphia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Syncope in Group 1 pulmonary arterial hypertension (PAH) is an independent predictor of poor prognosis in adults, but this is not well studied in children. We hypothesise that syncope in children with PAH often occurs in association with a reactive pulmonary vascular bed with sudden vasoconstriction in response to adverse stimuli. In the current study, we sought to determine the association of syncope with acute vasoresponsiveness and outcomes in children with Group 1 PAH. Methods: A retrospective chart review of children with PAH at a single pulmonary hypertension centre from 1 January 2005 to 31 October 2018 was performed. Data included demographics, symptoms, imaging, haemodynamics, and outcomes at baseline and follow-up. Results: 169 children had Group 1 PAH; 47 (28%) had syncope at presentation or follow-up. Children with significant shunts were excluded from the analysis. Children with syncope were older at diagnosis (7.5 Conclusions: Children with syncope had higher rates of vasoreactivity compared to those without. This suggests that in some children with PAH, syncope may simply reflect acute pulmonary vasoconstriction to an adverse stimulus. Larger prospective studies are warranted to further assess syncope as a marker for a vasoreactive phenotype with implications for treatment and long-term outcomes.

Identifiers

PMID36225331
PMCPMC9549342
OpenAlexW4289845915

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.